Stock listing
Stuttgart:S49 Supernus Pharmaceuticals, Inc. Aktie
German listing (Stuttgart) of Supernus Pharmaceuticals, Inc. · home listing NASDAQ:SUPN
Follow Supernus Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SUPN
$41.92 USD +0.08 (+0.2%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SUPN
- Day range
- $39.53 – $43.72 USDOct 30, 2026
- Volume
- 2.82M sharesOct 30, 2026
- Market cap
- $2.44B USDAt the close on Oct 30, 2026 · price × 58.22M shares outstanding
- 52-week range
- $37.54 – $59.68 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $39.33M USDMedian day 684,900 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SUPN · Home | $41.92 USD | +0.08 (+0.2%) | 2,818,869 | $42.07 | $43.72 | $39.53 | $41.84 | Close on Oct 30, 2026 |
| LSE:0LB2 | $40.48 USD | -0.08 (-0.2%) | 1 | $40.48 | $40.48 | $40.48 | $40.56 | Close on Oct 27, 2026 |
| Frankfurt:S49 | €37.20 EUR | +0.80 (+2.2%) | — | €37.20 | €37.20 | €37.20 | €36.40 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SUPN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $41.92 | +0.08 | +0.2% | $42.07 | $43.72 | $39.53 | 2,818,869 | |
| $41.84 | +0.76 | +1.9% | $44.24 | $44.28 | $40.76 | 1,885,191 | |
| $41.08 | +0.12 | +0.3% | $40.46 | $41.18 | $39.69 | 1,035,062 | |
| $40.96 | +0.19 | +0.5% | $40.57 | $41.20 | $39.87 | 1,075,467 | |
| $40.77 | +0.07 | +0.2% | $40.72 | $40.87 | $39.58 | 881,002 | |
| $40.70 | -1.37 | -3.3% | $41.68 | $41.95 | $39.96 | 1,159,300 | |
| $42.07 | +0.86 | +2.1% | $41.52 | $42.09 | $40.73 | 937,400 | |
| $41.21 | -0.02 | 0.0% | $41.23 | $42.00 | $40.86 | 1,006,000 | |
| $41.23 | +1.39 | +3.5% | $39.95 | $41.74 | $39.77 | 1,240,300 | |
| $39.84 | +1.96 | +5.2% | $37.77 | $40.52 | $37.77 | 1,509,100 | |
| $37.88 | -1.69 | -4.3% | $39.49 | $39.50 | $37.54 | 1,441,600 | |
| $39.57 | -0.61 | -1.5% | $40.21 | $41.31 | $39.36 | 1,013,100 | |
| $40.18 | -1.83 | -4.4% | $41.93 | $43.26 | $39.97 | 906,700 | |
| $42.01 | -0.80 | -1.9% | $42.94 | $43.29 | $41.71 | 1,196,900 | |
| $42.81 | +0.14 | +0.3% | $42.67 | $43.20 | $41.90 | 914,600 | |
| $42.67 | +0.53 | +1.3% | $42.18 | $43.14 | $42.15 | 643,800 | |
| $42.14 | -0.91 | -2.1% | $42.41 | $43.41 | $41.14 | 684,200 | |
| $43.05 | +0.22 | +0.5% | $42.24 | $43.38 | $42.24 | 571,000 | |
| $42.83 | +0.07 | +0.2% | $42.86 | $43.12 | $41.40 | 748,300 | |
| $42.76 | +0.38 | +0.9% | $42.38 | $43.20 | $42.38 | 1,288,400 | |
| $42.38 | +0.20 | +0.5% | $42.47 | $43.15 | $41.88 | 739,800 | |
| $42.18 | -0.86 | -2.0% | $43.21 | $43.69 | $42.15 | 424,600 | |
| $43.04 | -0.93 | -2.1% | $44.03 | $44.18 | $43.03 | 685,600 | |
| $43.97 | -0.63 | -1.4% | $44.39 | $44.93 | $43.20 | 551,600 | |
| $44.60 | +1.94 | +4.5% | $42.59 | $44.61 | $42.38 | 728,100 | |
| $42.66 | -0.63 | -1.5% | $43.21 | $43.69 | $42.65 | 607,600 | |
| $43.29 | -0.10 | -0.2% | $43.22 | $44.00 | $42.77 | 589,000 | |
| $43.39 | -0.36 | -0.8% | $43.66 | $44.46 | $43.14 | 544,500 | |
| $43.75 | +0.97 | +2.3% | $43.04 | $44.25 | $42.82 | 667,600 | |
| $42.78 | +0.78 | +1.9% | $42.00 | $42.97 | $41.68 | 635,700 | |
| $42.00 | -0.92 | -2.1% | $42.89 | $42.89 | $41.60 | 1,182,900 | |
| $42.92 | +1.54 | +3.7% | $41.66 | $43.40 | $41.46 | 559,800 | |
| $41.38 | +0.10 | +0.2% | $41.31 | $41.84 | $40.75 | 787,800 | |
| $41.28 | -0.21 | -0.5% | $41.49 | $41.75 | $40.51 | 669,200 | |
| $41.49 | -0.15 | -0.4% | $42.16 | $42.54 | $41.23 | 678,100 | |
| $41.64 | -0.05 | -0.1% | $41.81 | $42.44 | $41.62 | 707,200 | |
| $41.69 | -0.38 | -0.9% | $41.84 | $42.55 | $41.11 | 726,700 | |
| $42.07 | -0.36 | -0.8% | $42.17 | $42.59 | $41.50 | 580,100 | |
| $42.43 | -1.10 | -2.5% | $43.56 | $43.56 | $42.32 | 428,600 | |
| $43.53 | -0.44 | -1.0% | $43.66 | $44.11 | $43.43 | 444,200 | |
| $43.97 | -0.06 | -0.1% | $44.56 | $44.56 | $43.16 | 390,300 | |
| $44.03 | +0.29 | +0.7% | $44.42 | $45.05 | $43.67 | 445,900 | |
| $43.74 | -0.47 | -1.1% | $44.35 | $44.75 | $43.53 | 757,800 | |
| $44.21 | +0.48 | +1.1% | $43.82 | $44.37 | $42.84 | 535,700 | |
| $43.73 | -0.46 | -1.0% | $43.95 | $44.34 | $43.12 | 487,800 | |
| $44.19 | -0.69 | -1.5% | $44.87 | $45.04 | $43.89 | 464,900 | |
| $44.88 | -0.48 | -1.1% | $45.11 | $45.43 | $44.50 | 499,700 | |
| $45.36 | +0.25 | +0.6% | $45.37 | $45.86 | $44.23 | 496,056 | |
| $45.11 | -0.74 | -1.6% | $45.60 | $45.86 | $44.82 | 495,505 | |
| $45.85 | -1.60 | -3.4% | $47.71 | $47.82 | $45.79 | 748,900 | |
| $47.45 | -1.09 | -2.2% | $47.86 | $48.26 | $46.93 | 646,900 | |
| $48.54 | -0.49 | -1.0% | $49.50 | $49.82 | $48.51 | 797,200 | |
| $49.03 | +0.76 | +1.6% | $48.80 | $49.57 | $48.54 | 592,200 | |
| $48.27 | 0.00 | 0.0% | $47.66 | $48.66 | $47.66 | 536,700 | |
| $48.27 | +1.12 | +2.4% | $46.70 | $48.39 | $46.57 | 331,700 | |
| $47.15 | -0.72 | -1.5% | $47.74 | $48.18 | $46.87 | 667,900 | |
| $47.87 | +0.99 | +2.1% | $47.15 | $47.92 | $46.26 | 667,300 | |
| $46.88 | -0.19 | -0.4% | $47.01 | $48.61 | $46.77 | 669,685 | |
| $47.07 | -0.57 | -1.2% | $47.11 | $47.72 | $46.47 | 762,174 | |
| $47.64 | +0.88 | +1.9% | $47.00 | $47.88 | $46.43 | 702,600 | |
| $46.76 | -0.15 | -0.3% | $47.82 | $48.40 | $46.55 | 1,344,900 | |
| $46.91 | +3.66 | +8.5% | $42.95 | $47.89 | $42.91 | 1,671,800 | |
| $43.25 | -2.75 | -6.0% | $46.23 | $46.58 | $42.63 | 3,705,500 | |
| $46.00 | +1.37 | +3.1% | $50.45 | $52.50 | $44.17 | 4,518,500 | |
| $44.63 | -0.98 | -2.1% | $45.19 | $45.67 | $44.35 | 573,600 | |
| $45.61 | -0.96 | -2.1% | $46.30 | $46.77 | $45.50 | 466,900 |
- Ticker
- Stuttgart:S49
- Asset type
- Stock
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
Supernus Announces Third Quarter 2026 Financial Results
Latest earnings call · Oct 29, 2026
Supernus Pharmaceuticals (NASDAQ:SUPN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 29, 2026
Q3 2026 Earnings Presentation
Earnings · 7 slides
Calls
Replays
Supernus Pharmaceuticals (NASDAQ:SUPN) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 4:30 PM ET
Watch TranscriptSupernus Pharmaceuticals (NASDAQ:SUPN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 4:30 PM ET
Watch TranscriptSupernus Pharmaceuticals (NASDAQ:SUPN) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Supernus Announces Third Quarter 2026 Financial Results
Oct 29, 2026
Closed $41.92 (+0.2%) on Oct 30, 2026
Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign
Oct 28, 2026
Closed $41.08 (+0.3%) on Oct 28, 2026
Supernus Announces Orphan Drug Exclusivity for ONAPGO™ (apomorphine HCl)
Oct 21, 2026
Closed $42.07 (+2.1%) on Oct 22, 2026
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Oct 19, 2026
Closed $39.84 (+5.2%) on Oct 19, 2026
Chloe Kim Teams Up with Qelbree®, the #1 Prescribed Branded Non-Stimulant ADHD Treatment*, to Help Empower People Navigating ADHD
Aug 31, 2026
Closed $44.21 (+1.1%) on Aug 31, 2026
Supernus Announces Second Quarter 2026 Financial Results
Aug 3, 2026
Closed $46.00 (+3.1%) on Aug 3, 2026
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Aug 3, 2026
Closed $46.00 (+3.1%) on Aug 3, 2026
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
Jul 22, 2026
Closed $47.19 (+0.5%) on Jul 23, 2026
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
Jul 14, 2026
Closed $46.66 (-1.5%) on Jul 14, 2026
Supernus Expands Partnership With MERGE as AI-Powered Agency of Record
Jun 17, 2026
Closed $43.58 (0.0%) on Jun 17, 2026
Decks
Q3 2026 Earnings Presentation
Earnings · 7 slides · Oct 29, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 11 slides · Aug 3, 2026
Merger or Acquisition (August 2026)
Merger or acquisition · 13 slides · Aug 3, 2026
Investor Presentation (May 2026)
Investor deck · 35 slides · May 2026
Supernus Pharmaceuticals, Inc. on 6ix
- News releases
- 21 in the last 12 months · 160 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Oct 29, 2026
- Decks
- 17 decks · latest Oct 29, 2026
Where Supernus Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SUPN · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A1JX3U | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1JX3U | LS Exchange | Germany | EUR |
| gettex:S49 | gettex | Germany | EUR |
| BOATS:SUPN | BOATS | United States | USD |
| LSE:0LB2 | LSE | United Kingdom | USD |
| Frankfurt:S49 | Frankfurt | Germany | EUR |
| BX Swiss:S49 | BX Swiss | Switzerland | CHF |
| Dusseldorf:S49 | Dusseldorf | Germany | EUR |
| Munich:S49 | Munich | Germany | EUR |
| Stuttgart:S49 · This page | Stuttgart | Germany | EUR |
| Tradegate:S49 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Supernus Pharmaceuticals, Inc.